Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
101.7 GBX | +1.71% | -11.56% | -11.56% |
Business Summary
Number of employees: 24
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Short
FOU | Founder | 55 | 01/18/01 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 17/23/17 |
Iqbal Gill
CTO | Chief Tech/Sci/R&D Officer | - | - |
Arthur Wakeley
PRN | Corporate Officer/Principal | - | - |
Burleigh Abbott
PRN | Corporate Officer/Principal | - | - |
Kerin Williams
SEC | Corporate Secretary | 46 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Firth
BRD | Director/Board Member | 62 | - |
Ian Anton
CHM | Chairman | 64 | 28/22/28 |
Robert Barr
BRD | Director/Board Member | 65 | 28/22/28 |
Steven Hajioff
BRD | Director/Board Member | 58 | 28/22/28 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 17/23/17 |
James Short
FOU | Founder | 55 | 01/18/01 |
Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,208,903 | 21,738,143 ( 33.86 %) | 0 | 33.86 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-11.56% | 80.19M | |
+33.25% | 699B | |
+25.00% | 571B | |
-3.55% | 364B | |
+18.16% | 326B | |
+4.36% | 286B | |
+15.47% | 236B | |
+5.47% | 198B | |
-9.82% | 194B | |
-3.69% | 149B |
- Stock Market
- Equities
- CEL Stock
- Company Celadon Pharmaceuticals Plc